We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
TORONTO, April 08, 2024--Satellos Bioscience Inc. ("Satellos" or the "Company") (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, announced today that management will present at and participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16th and 17th in Toronto.
Announced today its financial results and operational highlights for the year ended December 31, 2023. ...